|Manufacturer||Intas Pharmaceuticals, India|
|Pack Size||Qty||Price Per Pill or Unit||Price||Cart|
|30 Tablet/s||US$ 0.67||US$ 20.00|
|60 Tablet/s||US$ 0.67||US$ 40.00|
|100 Tablet/s||US$ 0.60||US$ 60.0010%US$ 66.60|
Glycolate 2 mg
Glycolate 2 mg is medicine for intestinal ulcers. It contains the active ingredient Glycopyrrolate, which reduces the secretions in the throat, mouth, and stomach after surgery. You may get it in combination with other drugs to cure peptic ulcers. Glycopyrrolate is an anticholinergic drug which inhibits the action of acetylcholine on nerves and smooth muscles. This cause a significant reduction in the gastric secretions and excessive tracheal, pharyngeal, and bronchial secretions.
What are the uses of Glycolate 2 mg
Glycolate 2 mg is used as adjunctive therapy in the management of peptic/intestinal ulcers. It also helps in controlling drooling and excessive salivation caused by a certain mouth disease.
What is the dosage regimen?
The dosage of Glycolate tablets should be confirmed or adjusted to the needs of the individual patients to gain control with the minimum side effects. Usually, the recommended daily dose of glycopyrrolate tablets is one tablet thrice daily. A patient may distribute three doses evenly between the morning, early afternoon, and at bedtime. Some patients may require taking two tablets at bedtime to reduce the likeliness of overnight symptoms. The dose may further decrease to one tablet twice daily. Be sure to follow the dosage regimen given by your doctor. Do not make any changes without having words with your doctor.
What are the side effects?
Side effects to anticholinergic drugs, in general, may include decreased sweating, urinary retention, palpitations, blurred vision, tachycardia, increased ocular tension, headaches, nervousness drowsiness, weakness, insomnia and stomach problems.
What are the precautions?
Use glycolate 2 mg tablets with caution in the elderly patients with the renal disorder, hepatic insufficiency, heart disease, Ulcerative colitis, autonomic neuropathy. And hiatal hernia associated with acid reflux. Since the safety and efficacy of Glycolate 2 mg has not been established in the clinical studies, the medicine should not be given to these patients. Also, there is evidence that can approve the effectiveness of this anticholinergic drug. The use of Glycopyrrolate requires that the benefits of the medicine be weighed against the risks to mother and child. There are no studies to establish the safety of this medicine in pregnant women. Therefore, it is essential to consult a doctor before taking anticholinergics. It is not known whether the drug is excreted into breast milk. So, nursing should not be undertaken while a patient is receiving a therapeutic treatment, since it may excrete to breast milk.